Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.90    0.00 (0.00%)
Bid:
19.20
Ask:
20.10
Spread: 0.90 (4.688%)
Market Cap: €110.59b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Buy Back Program - Terms and Conditions 2º Segment

29 Jun 2022 08:13

RNS Number : 6140Q
Banco Bilbao Vizcaya Argentaria SA
29 June 2022
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the Spanish Securities Market legislation, hereby proceeds to notify the following:

 

 

INSIDE INFORMATION

 

 

 

Further to the notice of Inside Information of 28 June 2022, with CNMV registration number 1511 (the "Second Segment Execution II")[1], BBVA hereby notifies the execution of the Second Segment which completes the Program Scheme pursuant to Regulation (EU) No. 596/2014 of the European Parliament and of the Council, of 16 April 2014, on market abuse ("MAR") and Commission Delegated Regulation (EU) No. 2016/1052, of 8 March 2016, (the "Delegated Regulation" and, together with MAR, the "Regulations") under the terms and conditions detailed below:

 

 

Purpose:

To reduce BBVA's share capital by means of the redemption of the acquired shares.

 

Maximum cash amount:

 

The maximum cash amount will be 1,000 million Euros.

 

Maximum number of shares:

 

The maximum number of BBVA shares to be acquired will be 149,996,808.

Start of the execution:

Execution will start on 1 July 2022.

End of the execution:

The Second Segment will end no later than 29 September 2022 and, in any event, when the maximum cash amount is reached or the maximum number of shares is acquired.

 

However, the Company reserves the right to temporarily suspend or to early terminate the execution of the Second Segment in the event of any circumstance that so advises or requires.

Trading venue:

The acquisitions will be made on the Spanish Electronic Trading Interconnection System - Continuous Market (the "Continuous Market").

Manager:

The execution will be carried out externally through CITIGROUP GLOBAL MARKETS EUROPE AG (the "Manager"), who will make its decisions concerning the timing of the purchases of the BBVA shares independently of the Company.

Conditions of the Second Segment:

The Second Segment will be executed pursuant to the following conditions:

(i) by purchasing in each trading session on the Continuous Market (other than a Discontinued Day) 4,250,000 shares (the "Daily Target Number of Shares"), except in cases of force majeure or if the Manager is unable to purchase such number of shares due to limitations derived from the provisions of article 3.2 of the Delegated Regulation.

For these purposes, a Discontinued Day is understood to be any trading session of the Continuous Market in which there is a significant disruption in the market or in the quotation of the BBVA shares (including if their trading price falls below their nominal value during a substantial part of the session) or if the trading volume for the BBVA share is less than 2.5 times the Daily Target Number of Shares.

(ii) The own shares will be purchased respecting in all cases the conditions and the price and volume limits set forth in the Regulations.

In particular, it is hereby stated that the Daily Target Number of Shares is less than 25% of the average daily volume of the BBVA shares in the Spanish Electronic Trading Interconnection System - Continuous Market in the month preceding this communication (thus complying with the provisions of article 3.3.a) of the Delegated Regulation).

 

 

 

The share purchase transactions carried out, as well as the completion or, as the case may be, the interruption of the execution of the Second Segment, will be duly reported to the Spanish National Securities Market Commission in accordance with the Regulations.

 

 

Madrid, 29 June 2022


[1] The terms Second Segment and Program Scheme will have the same meaning as provided in the Second Segment Execution II.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLMRTMTBTMMT
Date   Source Headline
9th Dec 202510:30 amRNSPeriodic Report on the Buyback Program 2025/12/09
1st Dec 202510:25 amRNSPeriodic Report on the Buyback Program 2025/12/01
24th Nov 202510:42 amRNSPeriodic Report on the Buyback Program 2025/11/24
17th Nov 202510:44 amRNSPeriodic Report on the Buyback Program 2025/11/17
11th Nov 202511:13 amRNSPeriodic Report on the Buyback Program 11/11/2025
3rd Nov 20255:56 pmRNSIssuance of securities contingently convertible
30th Oct 20256:22 pmRNSPrudential capital requirements for 2026
30th Oct 20257:00 amRNS3Q25 Earnings Press Release
30th Oct 20257:00 amRNS3Q25 Earnings Report
30th Oct 20257:00 amRNS3Q25 Earnings Presentation
30th Oct 20257:00 amRNSExecution of a temporary own share buyback program
23rd Oct 202511:25 amRNS3Q25 Earnings Presentation Announcement
17th Oct 20257:00 amRNSPress release in relation to the VTO B.Sabadell
14th Oct 202510:53 amRNSInformation in relation to the VTO for B. Sabadell
7th Oct 20252:11 pmRNSFitch has upgraded BBVAs rating
3rd Oct 202512:19 pmRNSMoodys has upgraded BBVA’s rating
30th Sep 20257:00 amRNSDividend November 2025
25th Sep 202512:59 pmRNSSupplement exemption doc referred VTO B.Sabadell
22nd Sep 202512:28 pmRNSInformation in relation to the VTO for B.Sabadell
22nd Sep 20257:28 amRNSP.R. improvement offer to B.Sabadell shareholders
22nd Sep 20257:25 amRNSAmendment of the terms of the VTO for B.Sabadell
16th Sep 202512:37 pmRNSS&P has upgraded BBVAs rating
5th Sep 202512:57 pmRNSExemption doc in relation to the VTO to B.Sabadell
5th Sep 202510:51 amRNSOffer to Banco Sabadell Shareholders Presentation
5th Sep 202510:49 amRNSPress release offer to Banco Sabadell shareholders
5th Sep 202510:02 amRNSAnnouncement Offer to Banco Sabadell Presentation
5th Sep 20257:00 amRNSInformation regarding the VTO for B.Sabadell
29th Aug 20255:35 pmRNSInformation regarding the VTO for B.Sabadell
13th Aug 20255:58 pmRNSEarly redemption of Senior Non-Preferred
11th Aug 20256:13 pmRNSInformation regarding the VTO for Banco Sabadell
4th Aug 20257:00 amRNS2025 EBA Stress Test
31st Jul 20257:07 amRNS2Q25 Results Press Release
31st Jul 20257:06 amRNS2Q25 Quarterly Report
31st Jul 20257:02 amRNS2Q25 Earnings Presentation
24th Jul 20257:00 amRNS2Q25 Earnings Presentation Announcement
30th Jun 20255:32 pmRNSBBVA's decision on the takeover bid for Sabadell
25th Jun 20254:59 pmRNSIssuance of securities contingently convertible
24th Jun 20253:27 pmRNSAnnouncement on BBVA's takeover bid for Sabadell
12th Jun 20256:22 pmRNSBBVA Receives Updated MREL from Bank of Spain
27th May 20256:20 pmRNSInformation relation VTO launched BBVA-B.Sabadell
1st May 20257:00 amRNSAuthorisation of the CNMC
29th Apr 20254:51 pmRNS2024_Consolidated_Annual_Accounts&Management_Repor
29th Apr 20254:47 pmRNS2024_Individual_Annual_Accounts&Management_Report
29th Apr 20257:15 amRNS1Q25 Quarterly Report
29th Apr 20257:14 amRNSResults Press Release
29th Apr 20257:10 amRNS1Q25 Earnings Presentation
24th Apr 20257:00 amRNSRedemption of Public Sector Covered Bonds
24th Apr 20257:00 amRNSRedemption of Mortgage Covered Bonds
22nd Apr 202510:45 amRNS1Q 2025 earnings announcement
1st Apr 20255:26 pmRNSEarly redemption of Senior Preferred Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.